:

Fabio Luis-Silva1, Mayra Gonçalves Menegueti2, Leandro Moreira Peres1

  • 1Division of Intensive Care Medicine, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Frontiers in medicine
|October 29, 2024
PubMed
概括

甲蓝 (MB) 可能会减少在败血症休克患者的血管压缩剂的使用. 这项研究发现MB疗法在降低血管压缩剂剂量和增加IL-10水平方面是安全有效的.